REGENX Biosciences, LLC and Asklepios BioPharmaceutical, Inc. Enter Into Agreement for the Development of Treatments for Hemophilia A Using NAV(TM) rAAV8 Vectors
3/8/2012 8:49:39 AM
More...
|
Asklepios BioPharmaceutical, Inc. Enters Into A Patent License Agreement With Pfizer Inc. (PFE)
9/13/2010 11:52:38 AM
More...
|
Asklepios BioPharmaceutical, Inc.: Non-Profit Founded to Advance Orphan Drug Research
9/25/2007 10:23:49 AM
More...
|
Asklepios BioPharmaceutical, Inc.. Announces Cross License With GlaxoSmithKline (GSK)
9/28/2006 11:02:50 AM
More...
|
Asklepios BioPharmaceutical, Inc. And Bayer Healthcare, LLC Announce Collaboration On Gene Therapy For The Treatment Of Hemophilia
10/19/2005 5:10:00 PM
More...
|